FIXED COMBINATION OF THE CALCIUM CHANNEL BLOCKER LERCANIDIPINE AND ANGIOTENSIN CONVERTING ENZYME INHIBITOR ENALAPRIL: POSSIBILITY OF USAGE

<p>Data on the updated approach to the choice of two-component antihypertensive combinations for different clinical situations are presented. Advantages and indications for combination of an angiotensin converting enzyme (ACE) inhibitor and dihydropyridine calcium antagonist are considered. Da...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: O. D. Ostroumova, I. I. Kopchenov
Format: Artigo
Jezik:Inglês
Izdano: Stolichnaya Izdatelskaya Kompaniya 2015-09-01
Serija:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Teme:
артериальная гипертония
комбинированная терапия
фиксированные комбинации антигипертензивных препаратов
ингибиторы АПФ
антагонисты кальция
эналаприл
лерканидипин
Online pristup:http://www.rpcardio.ru/jour/article/view/284
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items